Vestal Point Capital’s Sanofi SNY Stock Holding History

Vestal Point Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.5M	Buy	+1,400,000	New	+$65.3M	1.89%	15
2025 Q1	–	Sell	-750,000	Closed	-$36.2M	–	81
2024 Q4	$36.2M	Buy	750,000 +600,000	+400%	+$30.5M	2.14%	18
2024 Q3	$8.64M	Buy	+150,000	New	+$8.1M	0.66%	36
2024 Q1	–	Sell	-300,000	Closed	-$14.9M	–	73
2023 Q4	$14.9M	Buy	+300,000	New	+$14.7M	1.58%	22

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vestal Point Capital's SNY Position: Q1 2026 in Review

Vestal Point Capital opened a new position in Sanofi (SNY) in Q1 2026: 1,400,000 shares worth $67.5M. The stake represents 1.89% of the portfolio and ranks #15 among its holdings. This is a return to the name: Vestal Point Capital previously reported a position in SNY as recently as Q4 2024.

Vestal Point Capital first reported a position in SNY in Q4 2023 and has held it in 4 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Vestal Point Capital held 1,400,000 shares of Sanofi worth $67.5M as of Q1 2026.
Sanofi was a new Vestal Point Capital position in Q1 2026.
Sanofi made up 1.89% of Vestal Point Capital's portfolio in Q1 2026, its #15 holding.
Vestal Point Capital first reported a position in Sanofi in Q4 2023 and has held it in 4 quarters since.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.